Viracta Therapeutics to Present at the Jefferies Virtual Healthcare Conference

Viracta Therapeutics, Inc. (Viracta or the Company), a precision oncology company targeting virus-associated malignancies, today announced that…

Stride Health’s Enrollment Platform powers CMS “Gig Workers’ Week of Action” with DoorDash, Postmates, Uber, Wonolo and more

Stride Health, the leading Portable Benefits platform for independent contractors, announced its participation in the “Gig…

Worldwide Milk Protein Concentrate Industry to 2027

The “Milk Protein Concentrate Market by Application and Concentration: Global Opportunity Analysis and Industry Forecast, 2021-2027” report has…

Dextrose Monohydrate Market is slated to expand at a CAGR of close to 5% over the 2021 to 2031

Dextrose monohydrate manufacturers is benefitting from rising demand for sweeteners sourced from natural ingredients and growing…

OnQuality Pharmaceuticals to Present on NOVA-II Trial Evaluating OQL011 at the 2021 ASCO and MASCC/ISOO Annual Meetings

OnQuality Pharmaceuticals (“OnQuality”), a targeted cancer supportive care company developing medications to address specific side effects…

Miravo Healthcare™ Announces Appointment of Mary Ritchie to its Board of Directors

Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian-focused healthcare…

NeuroBo Pharmaceuticals Reports First Quarter 2021 Financial Results

NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal disease-modifying therapies for…

Worldwide Healthcare Packaging Industry to 2026 – Profiles of Key Players

The “Healthcare Packaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026” report has been added…

GT Biopharma Reports First Quarter 2021 Results

GT Biopharma, Inc. (“GT Biopharma” or the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on…

Armata Pharmaceuticals Announces First Quarter Results and Provides General Corporate Update

 Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Company”), a biotechnology company focused on pathogen-specific…